SO
STRO icon

STRS Ohio’s Sutro Biopharma STRO Stock Holding History

STRS Ohio’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,280
Closed -$99.4K – 2300
2025
Q1 		$99.4K Hold
15,280
– – ﹤0.01% 1668
2024
Q4 		$281K Hold
15,280
– – ﹤0.01% 1397
2024
Q3 		$529K Sell
15,280
-1,250
-8% -$49K ﹤0.01% 1233
2024
Q2 		$484K Buy
16,530
+15,030
+1,002% +$594K ﹤0.01% 1272
2024
Q1 		$84K Buy
+1,500
New +$66.3K ﹤0.01% 1702
2020
Q3 		– Sell
-170
Closed -$13K – 2273
2020
Q2 		$13K Hold
170
– – ﹤0.01% 2081
2020
Q1 		$17K Hold
170
– – ﹤0.01% 1918
2019
Q4 		$18K Hold
170
– – ﹤0.01% 1984
2019
Q3 		$15K Hold
170
– – ﹤0.01% 1999
2019
Q2 		$19K Hold
170
– – ﹤0.01% 2032
2019
Q1 		$19K Hold
170
– – ﹤0.01% 1972
2018
Q4 		$15K Buy
+170
New +$20.5K ﹤0.01% 2006

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

STRS Ohio's STRO Position: Q2 2025 in Review

STRS Ohio sold out of Sutro Biopharma (STRO) in Q2 2025, closing a stake of 15,280 shares — an estimated $99.4K sold.

STRS Ohio first reported a position in STRO in Q4 2018 and held it in 12 quarters. The position peaked at $529K in Q3 2024. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2025.

  • STRS Ohio reported no remaining Sutro Biopharma position as of Q2 2025 after selling out during the quarter.
  • STRS Ohio sold 15,280 Sutro Biopharma shares in Q2 2025, an estimated $99.4K.
  • STRS Ohio first reported a position in Sutro Biopharma in Q4 2018 and held it in 12 quarters.
  • STRS Ohio's Sutro Biopharma position peaked at $529K in Q3 2024.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.